Use of Emerging Oral Anticoagulants in Clinical Practice: Translating Results from Clinical Trials to Orthopedic and General Surgical Patient Populations

@article{Merli2009UseOE,
  title={Use of Emerging Oral Anticoagulants in Clinical Practice: Translating Results from Clinical Trials to Orthopedic and General Surgical Patient Populations},
  author={G. Merli and A. Spyropoulos and J. Caprini},
  journal={Annals of Surgery},
  year={2009},
  volume={250},
  pages={219-228}
}
  • G. Merli, A. Spyropoulos, J. Caprini
  • Published 2009
  • Medicine
  • Annals of Surgery
  • Objective:A review of clinical data from oral anticoagulant studies in orthopedic/general surgery and extrapolation to actual clinical practice. Summary Background Data:In all surgical patients, there is a risk of postoperative venous thromboembolism (VTE). Parenteral unfractionated heparin, low-molecular-weight heparin, and fondaparinux are available for VTE prophylaxis. Vitamin K antagonists, the only available oral anticoagulants, are widely used in the United States for thromboprophylaxis… CONTINUE READING
    34 Citations
    Novel Oral Anticoagulants: Implications in the Perioperative Setting
    • 70
    • PDF
    Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
    • 69
    • PDF
    New and Generic Anticoagulants and Biosimilars: Safety Considerations
    • E. Kalodiki, J. Fareed
    • Medicine
    • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    • 2011
    • 11
    • PDF

    References

    SHOWING 1-10 OF 87 REFERENCES
    Update on Antithrombotic Therapy: New Anticoagulants
    • 359
    New Anticoagulants: Anti IIa vs Anti Xa—Is One Better?
    • 94
    The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement 1
    • 323
    • Highly Influential
    • PDF
    Investigational treatments of venous thromboembolism
    • 41